CTOs on the Move

Knight Therapeutics Inc

www.gud-knight.com

 
Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets. Knight Therapeutics' shares are expected to begin trading on the TSX-V on March 3, 2014 under the symbol GUD.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.gud-knight.com
  • 376 Victoria Ave Suite 220
    Westmount, ON CAN H3Z 1C3
  • Phone: 514.481.4116

Executives

Name Title Contact Details

Similar Companies

AerovectRx Corporation

AerovectRx Corporation is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Innovatient Solutions

Innovatient helps healthcare organizations deliver better care through an interactive patient experience and engagement technology platform. The highly customizable software provides an easy-to-use solution delivered via TV, tablet, or bedside monitor engaging patients during treatment and after they go home, fostering an environment of wellness and improved outcomes. Our integrated nurse rounding, communication, and patient education tools result in improved patient satisfaction scores (HCAHPS) transforming the patient experience creating long-term relationships with healthcare providers.

Marcon Group Inc

Marcon Group Inc is a San Rafael, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aspenpointe

Since 1875, AspenPointe has created help and hope for Colorado residents. We provide a broad range of services to meet individual and family needs in mental health, substance abuse, vocational skills training and employment, education, and restorative justice.

Contract Research Organization

WCCT Global is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.